Amgen’s Tavneos Receives NMPA Approval for ANCA-Associated Vasculitis Treatment in China
US biotechnology company Amgen (NASDAQ: AMGN) has announced that it has received market approval in...
CSL Vifor
CSL Vifor and Fresenius Kabi Win China Approval for Ferinject
Swiss firm CSL Vifor and Germany’s Fresenius Kabi have announced the first regulatory approval in...